{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:51:41Z","timestamp":1775595101205,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772044"],"award-info":[{"award-number":["81772044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11064-021-03424-9","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T09:02:57Z","timestamp":1629277377000},"page":"3213-3221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Overexpression of miR-378 Alleviates Chronic Sciatic Nerve Injury by Targeting EZH2"],"prefix":"10.1007","volume":"46","author":[{"given":"Pengfei","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Lu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Yun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"key":"3424_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.fob.2015.08.010","volume":"5","author":"MT Manners","year":"2015","unstructured":"Manners MT, Tian Y, Zhou Z, Ajit SK (2015) MicroRNAs downregulated in neuropathic pain regulate MeCP2 and BDNF related to pain sensitivity. FEBS Open Bio 5:733\u2013740","journal-title":"FEBS Open Bio"},{"issue":"3","key":"3424_CR2","first-page":"1509","volume":"41","author":"Y Liu","year":"2018","unstructured":"Liu Y, Wang L, Lao J, Zhao X (2018) Changes in microRNA expression in the brachial plexus avulsion model of neuropathic pain. Int J Mol Med 41(3):1509\u20131517","journal-title":"Int J Mol Med"},{"issue":"4","key":"3424_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","volume":"155","author":"O van Hecke","year":"2014","unstructured":"van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N (2014) Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155(4):654\u2013662","journal-title":"Pain"},{"issue":"3","key":"3424_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s12032-013-0675-8","volume":"30","author":"WC Zhang","year":"2013","unstructured":"Zhang WC, Liu J, Xu X, Wang G (2013) The role of microRNAs in lung cancer progression. Med Oncol 30(3):675","journal-title":"Med Oncol"},{"key":"3424_CR5","doi-asserted-by":"publisher","first-page":"218169","DOI":"10.1155\/2014\/218169","volume":"2014","author":"M Guz","year":"2014","unstructured":"Guz M, Rivero-Muller A, Okon E, Stenzel-Bembenek A, Polberg K, Slomka M, Stepulak A (2014) MicroRNAs-role in lung cancer. Dis Markers 2014:218169","journal-title":"Dis Markers"},{"key":"3424_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.nbd.2014.08.003","volume":"71","author":"HH Andersen","year":"2014","unstructured":"Andersen HH, Duroux M, Gazerani P (2014) MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions. Neurobio Dis 71:159\u2013168","journal-title":"Neurobio Dis"},{"issue":"10","key":"3424_CR7","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.1002\/jcb.27096","volume":"119","author":"Y Bao","year":"2018","unstructured":"Bao Y, Wang S, Xie Y, Jin K, Bai Y, Shan S (2018) MiR-28-5p relieves neuropathic pain by targeting Zeb1 in CCI rat models. J Cell Biochem 119(10):8555\u20138563","journal-title":"J Cell Biochem"},{"key":"3424_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainres.2018.04.038","volume":"1692","author":"PM Grace","year":"2018","unstructured":"Grace PM, Strand KA, Galer EL, Maier SF, Watkins LR (2018) MicroRNA-124 and microRNA-146a both attenuate persistent neuropathic pain induced by morphine in male rats. Brain Res 1692:9\u201311","journal-title":"Brain Res"},{"key":"3424_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27486","author":"LJ Ji","year":"2018","unstructured":"Ji LJ, Su J, Xu AL, Pang B, Huang QM (2018) MiR-134\u20135p attenuates neuropathic pain progression through targeting Twist1. J Cell Biochem. https:\/\/doi.org\/10.1002\/jcb.27486","journal-title":"J Cell Biochem"},{"issue":"1","key":"3424_CR10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/jcb.26269","volume":"119","author":"LJ Ji","year":"2018","unstructured":"Ji LJ, Shi J, Lu JM, Huang QM (2018) MiR-150 alleviates neuropathic pain via inhibiting toll-like receptor 5. J Cell Biochem 119(1):1017\u20131026","journal-title":"J Cell Biochem"},{"issue":"6","key":"3424_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s11064-018-2529-4","volume":"43","author":"DN Shi","year":"2018","unstructured":"Shi DN, Yuan YT, Ye D, Kang LM, Wen J, Chen HP (2018) MiR-183-5p alleviates chronic constriction injury-induced neuropathic pain through inhibition of TREK-1. Neurochem Res 43(6):1143\u20131149","journal-title":"Neurochem Res"},{"key":"3424_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.biopha.2018.08.053","volume":"107","author":"LY Zhan","year":"2018","unstructured":"Zhan LY, Lei SQ, Zhang BH, Li WL, Wang HX, Zhao B, Cui SS, Ding H, Huang QM (2018) Overexpression of miR-381 relieves neuropathic pain development via targeting HMGB1 and CXCR4. Biomed Pharmacother 107:818\u2013823","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3424_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3892\/ijmm.2016.2455","volume":"37","author":"L Li","year":"2016","unstructured":"Li L, Zhao G (2016) Downregulation of microRNA-218 relieves neuropathic pain by regulating suppressor of cytokine signaling 3. Int J Mol Med 37(3):851\u2013858","journal-title":"Int J Mol Med"},{"issue":"4","key":"3424_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/glia.22451","volume":"61","author":"G Shi","year":"2013","unstructured":"Shi G, Shi J, Liu K, Liu N, Wang Y, Fu Z, Ding J, Jia L, Yuan W (2013) Increased miR-195 aggravates neuropathic pain by inhibiting autophagy following peripheral nerve injury. Glia 61(4):504\u2013512","journal-title":"Glia"},{"issue":"3","key":"3424_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s11064-014-1500-2","volume":"40","author":"Y Tan","year":"2015","unstructured":"Tan Y, Yang J, Xiang K, Tan Q, Guo Q (2015) Suppression of microRNA-155 attenuates neuropathic pain by regulating SOCS1 signalling pathway. Neurochem Res 40(3):550\u2013560","journal-title":"Neurochem Res"},{"issue":"5","key":"3424_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1042\/CS20160571","volume":"131","author":"B Wang","year":"2017","unstructured":"Wang B, Yao K, Wise AF, Lau R, Shen HH, Tesch GH, Ricardo SD (2017) miR-378 reduces mesangial hypertrophy and kidney tubular fibrosis via MAPK signalling. Clin Sci (Lond) 131(5):411\u2013423","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"3424_CR17","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3892\/ijmm.2017.3116","volume":"40","author":"S Li","year":"2017","unstructured":"Li S, Yang F, Wang M, Cao W, Yang Z (2017) miR-378 functions as an onco-miRNA by targeting the ST7L\/Wnt\/beta-catenin pathway in cervical cancer. Int J Mol Med 40(4):1047\u20131056","journal-title":"Int J Mol Med"},{"issue":"5","key":"3424_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1139\/bcb-2017-0186","volume":"96","author":"N Peng","year":"2018","unstructured":"Peng N, Miao Z, Wang L, Liu B, Wang G, Guo X (2018) MiR-378 promotes the cell proliferation of osteosarcoma through down-regulating the expression of Kruppel-like factor 9. Biochem Cell Biol 96(5):515\u2013521","journal-title":"Biochem Cell Biol"},{"issue":"1","key":"3424_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3892\/ijmm.2012.1163","volume":"31","author":"Y Genda","year":"2013","unstructured":"Genda Y, Arai M, Ishikawa M, Tanaka S, Okabe T, Sakamoto A (2013) microRNA changes in the dorsal horn of the spinal cord of rats with chronic constriction injury: A TaqMan\u00ae Low Density Array study. Int J Mol Med 31(1):129\u2013137","journal-title":"Int J Mol Med"},{"key":"3424_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fped.2018.00328","volume":"6","author":"M Papale","year":"2018","unstructured":"Papale M, Ferretti E, Battaglia G, Bellavia D, Mai A, Tafani M (2018) EZH2, HIF-1, and their inhibitors: an overview on pediatric cancers. Front Pediatr 6:328","journal-title":"Front Pediatr"},{"issue":"2","key":"3424_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/bjc.2011.551","volume":"106","author":"CJ Chang","year":"2012","unstructured":"Chang CJ, Hung MC (2012) The role of EZH2 in tumour progression. Br J Cancer 106(2):243\u2013247","journal-title":"Br J Cancer"},{"key":"3424_CR22","doi-asserted-by":"publisher","first-page":"e02439","DOI":"10.7554\/eLife.02439","volume":"3","author":"WW Hwang","year":"2014","unstructured":"Hwang WW, Salinas RD, Siu JJ, Kelley KW, Delgado RN, Paredes MF, Alvarez-Buylla A, Oldham MC, Lim DA (2014) Distinct and separable roles for EZH2 in neurogenic astroglia. eLife 3:e02439","journal-title":"eLife"},{"key":"3424_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuroscience.2017.02.041","volume":"349","author":"R Yadav","year":"2017","unstructured":"Yadav R, Weng HR (2017) EZH2 regulates spinal neuroinflammation in rats with neuropathic pain. Neuroscience 349:106\u2013117","journal-title":"Neuroscience"},{"key":"3424_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"issue":"5","key":"3424_CR25","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3892\/ijo.2016.3689","volume":"49","author":"X Kuang","year":"2016","unstructured":"Kuang X, Wei C, Zhang T, Yang Z, Chi J, Wang L (2016) miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes. Int J Oncol 49(5):1921\u20131930","journal-title":"Int J Oncol"},{"key":"3424_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1479-5876-10-55","volume":"10","author":"M Redova","year":"2012","unstructured":"Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R, Slaby O (2012) Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med 10:55","journal-title":"J Transl Med"},{"issue":"3","key":"3424_CR27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ygyno.2014.03.564","volume":"133","author":"JK Chan","year":"2014","unstructured":"Chan JK, Kiet TK, Blansit K, Ramasubbaiah R, Hilton JF, Kapp DS, Matei D (2014) MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer. Gynecol Oncol 133(3):568\u2013574","journal-title":"Gynecol Oncol"},{"issue":"4","key":"3424_CR28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/bjc.2013.819","volume":"110","author":"S Zanutto","year":"2014","unstructured":"Zanutto S, Pizzamiglio S, Ghilotti M, Bertan C, Ravagnani F, Perrone F, Leo E, Pilotti S, Verderio P, Gariboldi M et al (2014) Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer. Br J Cancer 110(4):1001\u20131007","journal-title":"Br J Cancer"},{"key":"3424_CR29","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1186\/1471-2407-14-880","volume":"14","author":"F Megiorni","year":"2014","unstructured":"Megiorni F, Cialfi S, McDowell HP, Felsani A, Camero S, Guffanti A, Pizer B, Clerico A, De Grazia A, Pizzuti A et al (2014) Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members. BMC Cancer 14:880","journal-title":"BMC Cancer"},{"issue":"6","key":"3424_CR30","first-page":"7016","volume":"8","author":"B Li","year":"2015","unstructured":"Li B, Wang Y, Li S, He H, Sun F, Wang C, Lu Y, Wang X, Tao B (2015) Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma. Int J Clin Exp Pathol 8(6):7016\u20137021","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"3424_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3233\/CBM-181980","volume":"24","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Ma J (2019) miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion. Cancer Biomark 24(2):173\u2013181","journal-title":"Cancer Biomark"},{"issue":"5","key":"3424_CR32","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/cmi.2015.52","volume":"13","author":"S Liu","year":"2016","unstructured":"Liu S, Chen L, Zeng Y, Si L, Guo X, Zhou J, Fang D, Zeng G, Jiang L (2016) Suppressed expression of miR-378 targeting gzmb in NK cells is required to control dengue virus infection. Cell Mol Immunol 13(5):700\u2013708","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"3424_CR33","doi-asserted-by":"publisher","first-page":"e105702","DOI":"10.1371\/journal.pone.0105702","volume":"9","author":"Z Chen","year":"2014","unstructured":"Chen Z, Li C, Xu Y, Li Y, Yang H, Rao L (2014) Circulating level of miR-378 predicts left ventricular hypertrophy in patients with aortic stenosis. PloS one 9(8):e105702","journal-title":"PloS one"},{"issue":"3","key":"3424_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4143\/crt.2014.46.3.209","volume":"46","author":"H Yamaguchi","year":"2014","unstructured":"Yamaguchi H, Hung MC (2014) Regulation and role of EZH2 in cancer. Cancer Res Treat 46(3):209\u2013222","journal-title":"Cancer Res Treat"},{"issue":"2","key":"3424_CR35","first-page":"78","volume":"2","author":"H Zhao","year":"2013","unstructured":"Zhao H, Xu Y, Mao Y, Zhang Y (2013) Effects of EZH2 gene on the growth and migration of hepatocellular carcinoma HepG2 cells. Hepatobiliary Surg Nutr 2(2):78\u201383","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"3","key":"3424_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4161\/cbt.27306","volume":"15","author":"T Li","year":"2014","unstructured":"Li T, Cai J, Ding H, Xu L, Yang Q, Wang Z (2014) EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1. Cancer Biol Ther 15(3):271\u2013278","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"3424_CR37","doi-asserted-by":"publisher","first-page":"e71670","DOI":"10.1371\/journal.pone.0071670","volume":"8","author":"BP Coe","year":"2013","unstructured":"Coe BP, Thu KL, Aviel-Ronen S, Vucic EA, Gazdar AF, Lam S, Tsao MS, Lam WL (2013) Genomic deregulation of the E2F\/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer. PloS one 8(8):e71670","journal-title":"PloS one"},{"issue":"11","key":"3424_CR38","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1038\/s41375-018-0140-y","volume":"32","author":"N Rastgoo","year":"2018","unstructured":"Rastgoo N, Pourabdollah M, Abdi J, Reece D, Chang H (2018) Dysregulation of EZH2\/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS. Leukemia 32(11):2471\u20132482","journal-title":"Leukemia"},{"issue":"2","key":"3424_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3727\/096504013X13775486749218","volume":"21","author":"J Liang","year":"2013","unstructured":"Liang J, Zhang Y, Jiang G, Liu Z, Xiang W, Chen X, Chen Z, Zhao J (2013) MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma. Oncol Res 21(2):83\u201391","journal-title":"Oncol Res"},{"issue":"5","key":"3424_CR40","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.3892\/or.2014.3459","volume":"32","author":"K Zhang","year":"2014","unstructured":"Zhang K, Zhang Y, Ren K, Zhao G, Yan K, Ma B (2014) MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression. Oncol Rep 32(5):2143\u20132149","journal-title":"Oncol Rep"},{"issue":"1\u20132","key":"3424_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11010-014-2028-0","volume":"392","author":"L Xie","year":"2014","unstructured":"Xie L, Zhang Z, Tan Z, He R, Zeng X, Xie Y, Li S, Tang G, Tang H, He X (2014) MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer. Mol Cell Biochem 392(1\u20132):153\u2013159","journal-title":"Mol Cell Biochem"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03424-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-021-03424-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03424-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T04:09:13Z","timestamp":1634789353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-021-03424-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3424"],"URL":"https:\/\/doi.org\/10.1007\/s11064-021-03424-9","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"assertion":[{"value":"13 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee at Huai'an Second People's Hospital and The Affiliated Huai'an Hospital of Xuzhou Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}